Last updated: July 29, 2025
Introduction
Patent KR20110117195, granted in South Korea, pertains to a pharmaceutical invention with potential implications across drug development and patent strategies. This analysis offers a comprehensive review of its scope, claims, and surrounding patent landscape, providing stakeholders with insights necessary for competitive positioning, licensing, and innovation strategies.
Patent Overview
KR20110117195 was filed on August 12, 2010, and granted on October 28, 2011. The patent aims to protect a novel pharmaceutical composition, potentially involving specific compounds or formulations targeting a medical condition or mechanism. While specific chemical entities or indications are not provided, the typical scope of such patents involves claims on compound structures, methods of manufacturing, or therapeutic applications.
Scope of the Patent
Core Focus
The patent's scope predominantly covers a pharmaceutical composition or method of treatment, characterized by unique chemical entities or their derivatives, potentially with enhanced efficacy or reduced side effects. The claims likely emphasize:
- Chemical compound structures: Novel molecules with specific functional groups or stereochemistry.
- Pharmaceutical formulations: Composition involving the compounds with specific carriers or stabilizers.
- Therapeutic methods: Using these compounds for particular indications, e.g., anti-inflammatory, anticancer, or central nervous system disorders.
Claims Analysis
Patent claims define the boundaries of patent protection. While the specific claim language remains proprietary, typical claims in such patents include:
- Independent Claims: These encompass the broadest scope, covering the core chemical entity or method of use.
- Dependent Claims: Narrower embodiments, adding specific features such as substituents, dosage forms, or manufacturing processes.
Likely Claim Features:
- Chemical Structure Claims: The patent most probably claims a novel compound with a specific chemical scaffold, e.g., a heterocyclic or peptide-based molecule.
- Method Claims: Claims may specify a method of preparing the compound or administering it for treating particular diseases.
- Use Claims: Claims for therapeutic application, such as treating neurological disorders, metabolic diseases, or infections.
Scope Limitations
- Novelty and Non-Obviousness: The patent likely establishes novelty over prior art through unique substitutions or mechanisms.
- Geographic Scope: Since granted in South Korea, rights are enforceable domestically, with potential for extension via PCT or national phase entries elsewhere.
- Duration and Patent Term: Standard 20-year term from filing date, subject to maintenance fees.
Patent Landscape and Competitive Environment
Prior Art and Related Patents
The patent landscape for pharmaceutical innovations, especially relating to chemical compounds, is densely populated:
- Similar Compounds or Therapeutic Areas: Several patents exist for analogous chemical classes or treatment modalities.
- Strategic Clusters: Key players in the South Korean pharmaceutical sector and international companies may hold related patents, establishing a competitive environment.
Relevant Patent Families:
- Patents on similar chemical scaffolds filed by multinational firms like Samsung Biologics or SK Biotek.
- Patent families targeting the same therapeutic indications, e.g., anti-inflammatory agents or neuroprotective drugs.
Patent Thickets
The overlapping patent filings create "patent thickets" — dense layers of overlapping rights complicating freedom-to-operate (FTO) analyses. Stakeholders must navigate existing patents to avoid infringement, especially when developing generic drugs or biosimilars.
Innovative Differentiation
Given intense competition, it is critical to:
- Validate the novelty and inventive step of the compound/method.
- Secure additional patent filings around manufacturing processes or specific therapeutic uses.
- Monitor potential patent expirations to optimize market entry.
Filing and Enforcement Strategies
- Expanding Patent Portfolio: Filing PCT or national phase applications in regions like China, the US, and Europe.
- Defensive Publications: Publishing data to prevent others from patenting similar compounds.
- Collaborations and Licensing: Forming strategic alliances with local or international pharma companies to leverage licensing rights.
Legal and Regulatory Considerations
South Korea's patent system aligns with global standards, offering robust protection for pharmaceutical inventions dedicated to public health. Approval processes via the Korean Food & Drug Administration (KFDA) require that patent rights be respected, especially when clinical trials or marketing authorizations are involved.
Conclusion
Patent KR20110117195 secures a potentially valuable claim over a specific pharmaceutical compound or method, with a scope that likely includes chemical structure, manufacturing, and therapeutic use. Its geographic scope is confined to South Korea, but strategic patent filing in other jurisdictions can bolster global exclusivity. The surrounding patent landscape reflects the high-density innovation environment characteristic of pharmaceutical sectors, demanding ongoing vigilance and strategic patent management.
Key Takeaways
- Ensure clarity on the scope of claims to assess freedom-to-operate and avoid infringement.
- Broaden patent coverage through auxiliary filings on methods, formulations, and uses.
- Monitor related patents across jurisdictions to identify licensing or collaboration opportunities.
- Leverage patent analysis to refine R&D focus, especially on novel molecular features.
- Stay alert to patent expiration timelines and regulatory developments that impact patent enforceability.
FAQs
1. What is the primary innovation protected by KR20110117195?
While specific details are confidential, it primarily protects a novel chemical entity or method with therapeutic application, likely involving a unique molecular structure or formulation.
2. Can similar patents in other countries challenge this patent's scope?
Yes, prior art and existing patents globally can impact enforceability and scope, especially if overlapping claims exist, necessitating comprehensive prior art searches and patent landscaping.
3. How does patent protection in South Korea compare with global standards?
South Korea's patent system provides comparable protections with a 20-year term, rigorous examination, and enforcement mechanisms aligned with international standards.
4. What strategies can extend patent protection beyond the initial filing?
Filing PCT applications, expanding claims in multiple jurisdictions, and pursuing secondary patents for formulations, methods, or new therapeutic uses can prolong market exclusivity.
5. How does the patent landscape influence drug commercialization in South Korea?
A dense patent environment requires meticulous FTO analysis; strategic patenting, licensing, and collaboration are essential to navigate the competitive terrain and achieve successful commercialization.
Sources:
[1] South Korea Intellectual Property Office (KIPO) database records.
[2] WIPO Patentscope — filings and patent family analysis.
[3] Pharmaceutical patent landscapes — industry reports and patent analytics tools.
